Intus Biosciences LLC
Publicly observedFarmington, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Farmington | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Intus Biosciences LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | CJ9VLH9CVBJ4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant19 Aug 2026Publicly observed
NIH SBIR/STTR award: Non-Invasive, Bacterial-Based Early-Onset Colorectal Screen
USD 404,338.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Aug 2025Publicly observed
NIH SBIR/STTR award: Breakthrough High-Accuracy, High-Throughput Colorectal Cancer Screening Platform
USD 405,973.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.